Immutep Limited (IMMP) Receives FDA Orphan Drug Designation for Efti in Soft Tissue Sarcoma
TheFly reported on April 15 that IMMP announced that the U.S.
Immutep Ltd (IMMP)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Two Sigma Advisors John Overdeck And David Siegel | 124,760 | $43,791 | 0% | |
| 2. | Citadel Investment Group Ken Griffin | 78,174 | $27,439 | 0% | |
| 3. | Millennium Management Israel Englander | 20,802 | $7,302 | -81% | 0% |
| 4. | 16,000 | $5,616 | 0% | ||
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 0 | $0 | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 810,926 | $284,635 | 0% | |
| 2. | 748,811 | $262,833 | 0% | |
| 3. | 449,550 | $157,792 | 0.01% | |
| 4. | 73,837 | $25,917 | 0% | |
| 5. | 53,800 | $18,830 | 0.01% |
News See All
8 Oversold Biotech Stocks to Invest In Now
On February 5, J.P. Morgan revealed major themes that are expected to affect healthcare in 2026, emphasizing a resurgence of interest in the biopharma sector.
Immutep (IMMP) Scores Win After Announcing Deal With Indian Firm
Immutep Limited (NASDAQ:IMMP) is a biotechnology company developing therapies for cancer and autoimmune diseases. The firm’s shares underwent notable traction earlier this week after Indian firm Dr.
7 Best ASX Stocks to Buy Right Now
While the Federal Reserve cut interest rates in the US a couple of days back, in Australia, the trend appears to be moving in the opposite direction.
Immutep Limited (IMMP): Firm Reports Positive Data from Trials
In mid-November, Immutep Limited (NASDAQ:IMMP) reported positive data from two clinical trials of its drug candidate eftilagimod alpha, or efti.
11 Best Micro-Cap Stocks to Invest in According to Analysts
Micro-cap companies, generally referring to publicly traded businesses with less than $300 million in market capitalization, are among the most volatile and high-risk investments in the stock market.
Immutep Limited (IMMP) Receives Positive FDA Feedback on Future Clinical Development of Eftilagimod Alfa
Immutep Limited (NASDAQ:IMMP) is among the 12 Best Australian Stocks to Buy Right Now. On August 5, the company shared that it had received positive feedback from the U.S.
12 Best Australian Stocks to Buy Right Now
Australia’s S&P/ASX 200 index advanced 0.53% on Thursday to close at 8,873.80, with investors buoyed by gains in the banking sector, amid robust earnings and renewed hopes for further interest rate ...
Immutep (IMMP) Announces Positive Initial Efficacy Data and Continued Favourable Safety Data
Immutep Limited (NASDAQ:IMMP) is one of the 7 Best ASX Stocks to Buy Now.
7 Best ASX Stocks to Buy Now
While the Australian market is relatively well-positioned, it is vulnerable to broader market shocks, says SG Hiscock & Company (an Australian boutique investment manager).
Hedge Fund Resource Center